Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Smith & Nephew SNATS Inc (SNN)

  • Business News
  • June 03, 2026, 10:25 UTC
  • 3
  • 1 comments

Smith+Nephew PLC Notification

Market reaction Comment Full text

BENG KUANG MARINE LIMITED (BEZ)

  • Business News
  • June 03, 2026, 10:23 UTC
  • 3
  • 1 comments

Form 8.3

Market reaction Comment Full text

WORTHINGTON STEEL, INC. (WS)

  • Business News
  • June 03, 2026, 10:22 UTC
  • 3
  • 1 comments

Worthington Steel Completes Acquisition of Kloeckner & Co and Announces Intention to Launch Delisting Tender Offer

Market reaction Comment Full text

TAMAR PETROLEUM LTD (TMRP)

  • Business News
  • June 03, 2026, 10:19 UTC
  • 3
  • 1 comments

Approval of a motion to manage a claim as a class action regarding the issuance of Tamar Petroleum shares from July 2017, continued, learning

Market reaction Comment Full text

INOTIV, INC. (NOTV)

  • Business News
  • June 03, 2026, 10:15 UTC
  • 3
  • 1 comments

Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth

Market reaction Comment Full text

VILLAR INTERNATIONAL LTD. (VILR)

  • Business News
  • June 03, 2026, 10:13 UTC
  • 3
  • 1 comments

Trustee report to the holders of Series 11 - Hermetic Trust (1975) Ltd.

Market reaction Comment Full text

VILLAR INTERNATIONAL LTD. (VILR)

  • Business News
  • June 03, 2026, 10:10 UTC
  • 3
  • 1 comments

Trustee report to the holders of Series 9 - Hermetic Trust (1975) Ltd.

Market reaction Comment Full text

Mineralys Therapeutics Inc (MLYS)

  • Business News
  • June 03, 2026, 10:05 UTC
  • 3
  • 1 comments

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Market reaction Comment Full text

OBOOK HOLDINGS INC. (OWLS)

  • Business News
  • June 03, 2026, 10:05 UTC
  • 3
  • 1 comments

OwlTing Group (NASDAQ: OWLS) Secures Ohio Money Transmitter License, Extending U.S. Coverage to 42 States

Market reaction Comment Full text

MANNKIND CORP (MNKD)

  • Business News
  • June 03, 2026, 10:05 UTC
  • 3
  • 1 comments

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Market reaction Comment Full text
  • Previous
  • 1454
  • 1455
  • 1456
  • 1457
  • 1458
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351105)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192887)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin